Growing scientific evidence shows that climate change and the loss of nature and biodiversity are affecting the planet and the health of people in many ways, including: Extreme heat contributes to deaths from heat-related illnesses ; The increased spread of infectious diseases and air pollution exacerbate respiratory illnesses.
GSK today announced new and ambitious environmental sustainability goals, with the aim of having zero net climate impact and positive net impact on nature by 2030. This new milestone adds to the campaign #ConstruiendoFuturoGSK launched by GSK in Spain in June this year and which reflects the company’s commitment to the Sustainable Development Goals (SDGs) set by the United Nations (UN), in particular with the achievement of SDG 3 “ Health and wellness in an environment conditioned by COVID-19.
The new goals are part of one of the company’s three priorities, trusting and enhancing GSK’s environmental, social and governance (ESG) approach, supporting the company’s goal of creating long-term value. term for shareholders and meet the needs of the company. Over the next decade, GSK will invest in measures to reduce its environmental impact, in restoration programs to offset the impact the company cannot reduce, and aims to give back more to nature than the company. gets none.
In support of these goals, the company has established new goals in its various divisions, which include: 100% use of electricity from renewable energy sources and good water management in all GSK facilities; 100% use of sustainably sourced and deforestation-free materials and transition to electric vehicle use by 100% of GSK’s global sales force. For more information on objectives and goals, you can go to gsk.com.
Emma Walmsley, CEO of GSK, said: “As a global health-focused company, we want to play a full role in protecting and restoring the health of the planet, in order to protect and improve health. of people. Improving the environmental sustainability of our business also makes us more resilient, protecting our operations so that we can deliver the drugs, vaccines and products that patients and consumers trust. “And he adds that” As part of our priority of trust and ESG commitments, we are announcing a new level of ambition in our contribution to environmental sustainability, with the dual objective of ensuring that the new GSK company has an impact. net zero on climate and a net positive impact on nature by 2030. ”He ended by saying:“ All of us who work at GSK are very motivated by the challenge of achieving these new goals. To achieve them, you have to work working closely with third parties, including our suppliers, customers, consumers and patients, and we are grateful for their support. “
The new targets apply primarily to the biopharmaceuticals division of GSK. The Consumer Healthcare division within GSK will also contribute to these goals by achieving its own goals. Following the separation, the new Consumer Healthcare company will become a global leader and its new goals will reflect this, representing an important new level of ambition to achieve positive environmental change and help improve everyday health.
GSK has a long-standing commitment to reducing its environmental impact and was one of the first pharmaceutical companies to set ambitious environmental goals in 2010. Since then, in all of its operations, GSK has reduced its carbon emissions by 34 %, its waste in landfills by 78% and total water consumption by 31% (2019 figures).
The Science Based Targets initiative has proven that GSK’s new carbon targets are aligned with the more ambitious Paris Agreement goal of doing everything possible to ensure that global warming does not exceed 1.5 ° C. company will align itself with the Science Based Targets Network approach to measure its impact on nature and will seek to prove its purpose when the methodology is finalized.